Botanical species · safety record

Rosmarinus officinalis

The EFSA Compendium of Botanicals holds 16 constituent measurements, 5 adverse-effect records and 5 genotoxicity assays for Rosmarinus officinalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Rosmarinus officinalis L.

16Constituent measurements
10Safety records
7Cited sources
1,031Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1,031 licensed products naming Rosmarinus officinalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh

Source material stated

  • Aerial parts
  • Branch Leafy
  • Buds
  • Chlorella vulgaris - Broken Cell
  • Dried leaf
  • Entire dried plant
  • Flower
  • Flower tops

What the records describe

Constituents measured

  • Diterpenes7
  • 1,8-cineole2
  • Camphor2
  • Myrcene2
  • Carnosic acid1
  • L-piperitone1
  • Verbenone1

Plant parts

  • Unspecified11
  • Leaves7
  • Aerial part of plants3

Preparations

  • Essential oil8
  • Super-critical gas extraction8

Effect types

  • Digestive1
  • Hepatotoxicity1
  • Nephrotoxicity1
  • Neurotoxicity1
  • Not reported1

Target tissues

  • Brain1
  • Digestive1
  • Liver1
  • Urogenital: kidneys1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleUnspecifiedEssential oil52.2 PercentGC-MSResolve DOI
1,8-cineoleAerial part of plantsEssential oil22.01 PercentGC-MSResolve DOI
CamphorAerial part of plantsEssential oil7.57 PercentGC-MSResolve DOI
CamphorUnspecifiedEssential oil10.08 PercentGC-MSResolve DOI
Carnosic acidUnspecifiedSuper-critical gas extraction16.9 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesLeavesSuper-critical gas extraction≤ 2.7 Percent AreaHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesLeavesSuper-critical gas extraction≥ 0.6 Percent AreaHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesLeavesSuper-critical gas extraction≤ 3.9 Percent AreaHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesLeavesSuper-critical gas extraction≥ 2.7 Percent AreaHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesLeavesSuper-critical gas extraction≤ 6.3 Percent AreaHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesLeavesSuper-critical gas extraction≥ 5.2 Percent AreaHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
DiterpenesUnspecifiedSuper-critical gas extraction1.93 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
L-piperitoneUnspecifiedEssential oil6.68 PercentGC-MSResolve DOI
MyrceneUnspecifiedEssential oil2.61 PercentGC-MSResolve DOI
MyrceneAerial part of plantsEssential oil1.63 PercentGC-MSResolve DOI
VerbenoneLeavesEssential oil23.55 PercentGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestiveUnspecifiedNot reportedNo resolvable identifier
HepatotoxicityLiverUnspecifiedNot reportedNo resolvable identifier
NephrotoxicityUrogenital: kidneysUnspecifiedNot reportedNo resolvable identifier
NeurotoxicityBrainUnspecifiedNot reportedNo resolvable identifier
Not reportedUnspecifiedHuman (as organism)Case reportNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationMammalian erythrocyte micronucleus testRat (as animal)Resolve DOI
Positivegene mutationMammalian erythrocyte micronucleus testHouse mouse (as animal)Resolve DOI
PositiveDNA damage and/or repairsingle cell gel/comet assay in mammalian cells for detection of DNA damageHouse mouse (as animal)Resolve DOI
Positivechromosome aberrationin vitro gene mutation assay in fungiHuman (as organism)With and withoutResolve DOI
Positivechromosome aberrationchromosome aberration assayRat (as animal)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Maistro, E. L., Mota, S. F., Lima, E. B., Bernardes, B. M., Goulart, F. C. Genotoxicity and mutagenicity of Rosmarinus officinalis (Labiatae) essential oil in mammalian cells in vivo. Genetics and molecular research, 2010, vol. 9, no. 4, p. 2113-2122. DOI
  2. Contini, Adele., Di Bello, Domenica., Azzara, Alessia., Giovanelli, Silvia., D'Urso, Giuseppina., Piaggi, Simona., Pinto, Barbara., Pistelli, Luisa., Scarpato, Roberto., Testi, Serena. Assessing the cytotoxic/genotoxic activity and estrogenic/antiestrogenic potential of essential oils from seven aromatic plants. Food and chemical toxicology, 2020, vol. 138. DOI
  3. Loutfia, Toilabiya., Hinde, Hami., Abdelmajid, Soulaymani., Naima, Rhalem., Laheen, Ouammi., Doha, Benali., Adbelrhani, Mokhtari., Rachida, Soulaymani-Bencheikh. Poisoning by plants in the Taza-Al Hoceima-Taounate region in Morocco. Pakistan journal of scientific and industrial research, series b: biological sciences, 2013, vol. 56, no. 1, p. 23-28.
  4. Dimitrijevic, Suzana I., Mihajlovski, Katarina R., Antonovic, Dusan G., Milanovic-Stevanovic, Mirjana R., Mijin, Dusan Z. A study of the synergistic antilisterial effects of a sub-lethal dose of lactic acid and essential oils from Thymus vulgaris L., Rosmarinus officinalis L. and Origanum vulgare L.. Food chemistry, 2007, vol. 104, no. 2, p. 774-782. DOI
  5. Gudek, Melek., Cetin, Huseyin. Fumigant Toxicity on Adults of Callosobruchus maculatus (F.) (Coleoptera: Chrysomelidae) of Essential Oil from Rosmarinus officinalis L. and its Side Effects on Chickpea Grains. Journal of essential oil bearing plants, 2017, vol. 20, no. 1, p. 272-281.
  6. Anadon, Arturo., Martinez-Larranaga, Maria R., Martinez, Maria A., Ares, Irma., Garcia-Risco, Monica R., Senorans, Francisco J., Reglero, Guillermo. Acute oral safety study of rosemary extracts in rats. Journal of food protection, 2008, vol. 71, no. 4, p. 790-795. DOI
  7. Anadon, Arturo., Martinez, Maria A., Ares, Irma., Castellano, Victor., Martinez-Larranaga, Maria R., Corzo, Nieves., Olano, Agustin., Montilla, Antonia., Recio, Isidra., Martinez-Maqueda, Daniel., Miralles, Beatriz., Fornari, Tiziana., Garcia-Risco, Monica R., Gonzalez, Monserrat., Reglero, Guillermo. Acute and Repeated Dose (28 Days) Oral Safety Studies of ALIBIRD in Rats. Journal of food protection, 2013, vol. 76, no. 7, p. 1226-1239. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue